Business Context and Reporting Period
Company: Phibro Animal Health Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: February 3, 2026
Reporting Period: Specific event date (February 3, 2026)
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a corporate action regarding shareholder distributions.
Material Changes
The filing announces the declaration of a quarterly cash dividend. There are no reported material changes to operations, financial position, or capital structure other than the commitment to pay the declared dividend.
Guidance, Outlook, and Management Commentary
Dividend Declaration:
- Amount: $0.12 per share
- Applicable Shares: Class A Common Stock and Class B Common Stock
- Record Date: March 4, 2026
- Payment Date: March 25, 2026
Outlook and Risks: The filing text does not provide forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard incorporation of the press release.
Investor Verification Checklist
- Verify the record date (March 4, 2026) to ensure eligibility for the dividend.
- Confirm the payment date (March 25, 2026) for cash flow planning.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the dividend declaration.
- Note that this 8-K does not contain updated financial performance data; refer to the most recent 10-Q or 10-K for revenue and earnings metrics.